Abstract
The nucleus 1,2,4-triazole is found in a wide variety of biologically active molecules. Interest in 1,2,4-triazole chemistry in recent decades has been increasing rapidly because of diverse biological and pharmaceutical applications, mostly due to the diversity of this N-heterocyclic moiety in medicinal chemistry. More than 35 drugs containing this nucleus have been released on the market. The nucleus of the 1,2,4-triazole is metabolically stable and interacts as a pharmacophore by serving as a hydrogen bond acceptor and donor at the active site of a receptor. The triazole nucleus can improve the drug’s pharmacological profile by increasing the solubility of the ligand due to its polar character. This chapter highlights the unique features about the potential possible role of 1,2,4-triazole derivatives and summarizes biological, and pharmacological activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- U.S. FDA:
-
United State Food and Drug Administration
- HIV:
-
Human immunodeficiency virus
- NAD:
-
Nicotinamide adenine dinucleotide
- DNA:
-
Deoxyribonucleic acid
- HER2:
-
Human epidermal growth factor receptor 2
- COX:
-
Cyclooxygenase
- XPO1:
-
Exportin 1
- OAT4:
-
Organic anion carrier 4
- URAT1:
-
Uric acid carrier 1
- DPP-4:
-
Dipeptidyl peptidase-4
- PARP:
-
Poly(ADP-ribose)polymerase
- RNA:
-
Ribonucleic acid
- SAR:
-
Structure–activity relationship
- GLP-1:
-
Glucagon-like peptide 1
- AIDS:
-
Acquired immune deficiency syndrome
- GIP:
-
Gastric inhibitory polypeptide
- TNFα:
-
Tumour necrosis factor α
- HSV:
-
Herpes simplex viruses
- JNK:
-
Jun N-terminal kinase
References
Li Z, Cao Y, Zhan P, Pannecouque C, Balzarini J, Clercq ED, Liu X (2013) Synthesis and anti-HIV evaluation of novel 1,2,4-triazole derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors. Lett Drug Des Discov 10:27–34
Wade PC, Vogt BR, Kissick TP, Simpkins LM, Palmer DM, Millonig RC (1982) 1-Acyltriazoles as antiinflammatory agents. J Med Chem 25:331–333
Strzelecka M, ĹšwiÄ…tek P (2021) 1,2,4-triazoles as important antibacterial agents. Pharmaceuticals 14:224
Asif M (2015) Antiviral and antiparasitic activities of various substituted triazole derivatives: a mini review. Chem Int 1:71–80
El-Emary TI, El-Mohsen SAA (2012) Multi-component one-pot synthesis and antimicrobial activities of 3-methyl-1,4-diphenyl-7-thioxo-4,6,8,9 tetrahydropyrazolo[5,4-b]pyrimidino[5,4-e]pyridine-5-one and related derivatives. Molecules 17:14464–14483
Luo Y, Zhang S, Liu Z-J, Chen W, Fu J, Zeng Q-F, Zhu H-L (2013) Synthesis and antimicrobical evaluation of a novel class of 1,3,4-thiadiazole: derivatives bearing 1,2,4-triazolo[1,5-a]pyrimidine moiety. Eur J Med Chem 64:54–61
Abdelhamid AO, Fahmi AA, Ali AA (2013) Synthesis of some new fused azolopyrimidines, azolotriazines and pyridines containing coumarines moieties. Int J Adv Res 1:627–644
Nassar MY, Aly HM, Moustafa ME, Abdelrahman EA (2017) Synthesis, characterization and biological activity of new 3-substitued-4-amino-5-hydrazino-1,2,4-triazole Schiff bases and their Cu(II) complexes: a new approach to CuO nanoparticles for photocatalytic degradation of methylene blue dye. J Inorg Organomet Polym 27:1220–1233
Sayed HH, Morsy EMH, Felfel EM (2010) Synthesis and reactions of some novel nicotinonitrile, thiazolotriazole, and imidazolotriazole derivatives for antioxidant evaluation. Synth Commun 40:1360–1370
Valenti VE, Abreu LC, Sato MA, Ferreria C (2010) ATZ (3-amino-1,2,4-triazole) injected into the fourth cerebral ventricle influences the Bezold-Jarisch reflex in conscious rats. Clinics 65:1339–1343
Al-Salahi R, El-Tahir K-E, Alswaidan I, Lolak N, Hamidaddin M, Marzouk M (2014) Biological effects of a new set 1,2,4-triazolo[1,5-a]quinazolines on heart rate and blood pressure. Chem Cent J 8:3–10
Upadhyay K, Manvar A, Loddo R, La Colla P, Virsodiya V, Trivedi J, Chaniyara R, Shah A (2013) Syntheses and in vitro biological screening of 1-aryl-10H-[1,2,4]triazolo[3′,4′:3,4][1,2,4]triazino[5,6-b]indoles. Med Chem Res 22:3675–3686
Asif M (2017) Pharmacological activities of triazole analogues as antibacterial, antifungal, antiviral agents. Pharm Sci Asia 44:59–74
Boechat N, Pinheiro LCS, Silva TS, Aguiar ACC, Carvalho AS, Bastos MM, Costa CCP, Pinheiro S, Pinto AC, Mendonca JS, Dutra KDB, Valverde AL, Santos-Filho OA, Ceravolo IP, Krettli AU (2012) New trifluoromethyl triazolopyrimidines as anti-plasmodium falciparum agents. Molecules 17:8285–8302
Khrishna KM, Inturi B, Pujar GV, Purohit MN, Vijaykumar GS (2014) Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents. Eur J Med Chem 84:516–529
Shah MH, Mhasalkar MY, Patki VM, Deliwala CV, Sheth UK (1969) New 1,2,4(H)-triazole derivatives as diuretic agents. J Pharm Sci 58:1398–1401
Bera H, Dolzhenko AV, Sun L, Gupta SD, Chui WK (2013) Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors. Chem Biol Drug Des 82:351–360
Bera H, Chui WK, Gupta SD (2013) Synthesis, in vitro evaluation of thymidine phosphorylase inhibitory activity, and in silico study of 1,3,5-triazin-2,4-dione and its fused analogues. Med Chem Res 22:6010–6021
Hassan GS, El-Sherbeny MA, El-Ashmawy MB, Bayoumi SM, Maarouf AR, Badria FA (2013) Synthesis and antitumor testing of certain new fused triazolopyrimidine and triazoloquinazoline derivatives. Arab J Chem 10:1345–1355
Wu W-N, Jiang Y-M, Fei Q, Du H-T, Yang M-F (2020) Synthesis and antifungal activity of novel 1,2,4-triazole derivatives containing an amide moiety. J Heterocycl Chem 57:1379–1386
Xu J, Cao Y, Zhang J, Yu S, Zou Y, Chai X, Wu Q, Zhang D, Jiang Y, Sun Q (2011) Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives. Eur J Med Chem 46:3142–3148
Mange YJ, Isloor AM, Malladi S, Isloor S, Fun HK (2013) Synthesis and antimicrobial activities of some novel 1,2,4-triazole derivatives. Arab J Chem 6:177–181
Huang H, Guo W, Wu W, Li CJ, Jiang H (2015) Copper-catalyzed oxidative C(sp3)-H functionalization for facile synthesis of 1,2,4-triazoles and 1,3,5-triazines from amidines. Org Lett 17:2894–2897
Kuang J, Chena B, Ma S (2014) Copper-mediated efficient three-component synthesis of 1,2,4-triazoles from amines and nitriles. Org Chem Front 1:186–189
Blum RA, D’Andrea DT, Florentino BM, Hilligoss DM, Gardner MJ, Henry EB, Goldstein H, Schentag JJ (1991) Increased gastric pH and the bioavailability of fluconazole and ketoconazole. Ann Intern Med 114:755–757
Asif M (2016) Biological potentials of biological active triazole derivatives: a short review. Org Chem Curr Res 5:173
Kumudha D, Reddy RR, Kalavathi T (2012) 1,2,4-triazoles: as biologically important agents. Int J Pharm Sci Res 3:4562–4572
Asif M (2014) A brief review on antitubercular activity of pharmacological active some triazole analogues. Glob J Res Rev 1:51–58
Can NÖ, Çevik UA, Sağlık BN, Levent S, Korkut B, Özkay Y, Kaplancıklı ZA, Koparal AS (2017) Synthesis, molecular docking studies, and antifungal activity evaluation of new benzimidazole-triazoles as potential lanosterol 14α-demethylase inhibitors. J Chem 2017
Sinha J, Kadawla M (2017) Triazoles as antimicrobial: a review. Int J Chem Stud 5:1–7
Jadhav GR, Shaikh MU, Kale RP, Shiradkar MR, Gill CH (2009) SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents. Eur J Med Chem 44:2930–2935
Zhang HJ, Wang XZ, Cao Q, Gong GH, Quan ZS (2017) Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole. Bioorg Med Chem Lett 27:4409–4414
Kharb R, Sharma PC, Yar MS (2011) Pharmacological significance of triazole scaffold. J Enzyme Inhib Med Chem 26:1–21
Bing J, Hu T, Zheng Q, Muñoz JF, Cuomo CA, Huang G (2020) Experimental evaluation identifies adaptive aneuploidy as a mechanism of fluconazole resistance in candida auris. Antimicrob Agents Chemother 65:1–14
Heeres J, Meerpoel L, Lewi P (2010) Conazoles. Molecules 15:4129–4188
Griffin CE, Kaye AM, Beuno FR, Kaye AD (2013) Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J 13:214–223
Masiulis S, Desai R, Uchański T, Martin IS, Laverty D, Karia D, Malinauskas T, Zivanov J, Pardon E, Kotecha A, Steyaert J, Miller KW, Aricescu R (2019) GABAA receptor signalling mechanism revealed by structural pharmacology. Nature 565:454–459
Gallwitz B (2019) Clinical use of DPP-4 inhibitors. Front Endocrinol 10:1–10
Ryst EVD (2015) Maraviroc-a CCR5 antagonist for the treatment of HIV-1 infection. Front Immunol 6:1–4
Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, Li T, Ma L, Fenalti G, Li J, Zhang W, Xie X, Yang H, Jiang H, Cherezov V, Liu H, Stevens RC, Wu B (2013) Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science 341:1387–1390
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Kabi, A.K. et al. (2022). Overview on Medicinal Impacts of 1,2,4-Triazole Derivatives. In: Mukherjee, K., Layek, R.K., De, D. (eds) Tailored Functional Materials. Springer Proceedings in Materials, vol 15. Springer, Singapore. https://doi.org/10.1007/978-981-19-2572-6_5
Download citation
DOI: https://doi.org/10.1007/978-981-19-2572-6_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-2571-9
Online ISBN: 978-981-19-2572-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)